GlaxoSmithKline (GSK ... controller of Germany’s Stada and owner of UK consumer products maker Thornton & Ross. Stada already announced earlier this month it would buy a small portfolio of ...

He said that the growth prospects for consumer products are poor because of competition from store-brand generics, and online retailers like Amazon. What GSK does next will be a test of its new ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK announced several transactions involving ... and manufacture of pharmaceuticals, vaccines, and consumer healthcare products. The company operates in the pharmaceutical industry and has a ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... In a similar vein, the market has grown significantly due to consumer interest in weight-loss medications like Ozempic ...

Now that its hand has been revealed, there is no question that Unilever will do its best to acquire the consumer division of GlaxoSmithKline as it completes its demerger. Its £50bn offer may rise ...

GSK previously came under pressure from activists Elliott Investment Management and Bluebell Capital Partners. While both broadly agreed with the company’s plans to spin off its consumer-health ...

As GSK prepares to separate its pharma and consumer health divisions in 2022, the business has been focusing on using insight and analytics to fuel business growth, the MRS Semiotics and Cultural ...